fda glp-1 compounding crackdown news The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in bio Pharmacovigilance Assessment of Compounded GLP-1

GLP-1 receptor agonists are not recommended to be used during pregnancy, and so we can assume that the vast majority, if not all, of patients had stopped use either before or soon after conception, Nau told Healio

Dual GLP-1/GIP receptor agonist peptide with modifications enabling once-weekly injectable and once-daily oral administration

Cytochrome P450 mainly carry out a monooxygenation reaction and carry oxidation of drugs/xenobiotic compounds

Incorporating these data helps the model determine which input features most strongly influence target prediction, enabling more precise feature selection and fine-tuning of model parameters